The N1‐methyladenosine methyltransferase TRMT61A promotes bladder cancer progression and is targetable by small molecule compounds
Saved in:
Main Authors: | Jianjian Yin, Xin Fan, Qi Chang, Yuanheng Dai, Tao Wang, Lei Shi, Linlin Yang, Xiaoming Yang, Xudong Zhang, Lei Jin, Tao Liu, Fengmin Shao, Lirong Zhang, Dongkui Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1002/ctm2.70137 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recognition and cleavage of human tRNA methyltransferase TRMT1 by the SARS-CoV-2 main protease
by: Angel D'Oliviera, et al.
Published: (2025-01-01) -
Human TRMT1 and TRMT1L paralogs ensure the proper modification state, stability, and function of tRNAs
by: Kejia Zhang, et al.
Published: (2025-01-01) -
Methyltransferase-like 7B participates in bladder cancer via ACSL3 m6A modification in a ferroptosis manner
by: Jiani He, et al.
Published: (2025-01-01) -
RNA N6-Methyladenosine Modifications and the Immune Response
by: Ya-Nan Wang, et al.
Published: (2020-01-01) -
New insights into N6-methyladenosine in hepatocellular carcinoma immunotherapy
by: Mengran Li, et al.
Published: (2025-01-01)